On July 8th, Gelunhui revealed that its subsidiary, Northeast Pharmaceutical Group Shenyang First Pharmaceutical Co., Ltd. received a Drug Registration Certificate (Acceptance Number: CYHS2202151, Certificate Number: 2024S01432) approved and issued by the National Medical Products Administration for Voglibose Tablets.
The original manufacturer of Voglibose Tablets is Novartis AG, and its domestic product name is 'Jiaweile'. Voglibose Tablets are used to treat Type 2 diabetes.